Brokerages Set Immunic, Inc. (NASDAQ:IMUX) PT at $13.20
Shares of Immunic, Inc. (NASDAQ:IMUX – Get Free Report) have earned a consensus rating of “Buy” from the eight brokerages that are presently covering the stock, MarketBeat reports. Six research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average 1-year price objective […]
Shares of Immunic, Inc. (NASDAQ:IMUX – Get Free Report) have earned a consensus rating of “Buy” from the eight brokerages that are presently covering the stock, MarketBeat reports. Six research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average 1-year price objective […]
